Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qi Wu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gestational cardiovascular health and adverse pregnancy outcomes: a prospective cohort study in China

    by Qi Wu, Hao Ma, Yihui Wu, Shuqi Zhu, Jiayue Tang, Mengjia Hu, Yibo Tang, Luyao Hu, Lixia Zhang, Xiaolin Xu, et al.

    Pregnancy is considered a critical period for cardiovascular health (CVH) assessment and management. A large body of evidence has shown that poor gestational CVH is associated with higher risks of ...

  • Open Access

    A Novel Single-Test Approach for GDM Diagnosis: Identification and Prediction of High-Risk Postprandial Hyperglycemia

    by Hao Wu, Danqing Chen, Xue Li, Menglin Zhou, Qi Wu

    Background: Early prediction of gestational diabetes mellitus (GDM) remains a major clinical challenge, and the current oral glucose tolerance test (OGTT) is time-consuming and inconvenient for clinical routine. This study aimed to develop a novel predictive model for postprandial hyperglycemia GDM (pp-GDM) and postprandial glucose elevation using fasting serological and metabolic profiles. Method: We used High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) to analyze fasting plasma amino acid profiles at 24–28 weeks of gestation for 60 pp-GDM patients and 120 controls. Binary logistic regression model was constructed to identify potential biomarkers for pp-GDM prediction. Results: By incorporating amino acid indicators such as isoleucine, phenylalanine, threonine, and aspartate into the predictive model alongside traditional predictors (including BMI at sampling, fasting insulin, glycated hemoglobin, and uric acid), the overall predictive performance was significantly improved from 78.2% to 91.1%. A clinically practical nomogram for risk assessment was subsequently developed. Conclusions: This fasting metabolite-based model provides a reliable tool for early prediction of pp-GDM and postprandial hyperglycemia, which may reduce the need for OGTT and facilitate timely clinical decision making.


  • Open Access

    Metabolomics of saliva, serum, and urine for pathogenesis, diagnosis, and prognosis in gestational diabetes mellitus

    by Qi Wu, Yihui Wu, Shuqi Zhu, Yibo Tang, Lixia Zhang, Jiayue Tang, Qi Chen, Luyao Hu, Pingya Zhu, Xuliang Fu, et al.

    Gestational diabetes mellitus (GDM) is a common metabolic disorder in pregnancy, but the underlying mechanism has not been fully clarified. Using metabolomic profiling of second-trimester saliva, serum, and urine, we identify 54 metabolites altered in GDM that converge on key metabolic pathways. Fifty GDM biomarkers independently associated with abnormal maternal glucose and insulin resistance are selected to construct GDM discriminant models (internal test AUC: 0.868; real-world test: 0.796). These GDM biomarkers are also associated with clinical profiles and adverse outcomes, thereby predicting maternal and neonatal risks (internal test AUC: 0.764 and 0.838; real-world test: 0.726 and 0.792, respectively). Eleven GDM biomarkers are already altered in the first trimester, which can be used for the early prediction of GDM (internal test AUC: 0.767; real-world test: 0.744). In this work, changes and interactions of metabolites in saliva, serum, and urine in the second trimester are first identified in GDM, providing insights into its pathogenesis and potential early prediction and prevention strategies.


  • Open Access

    Psychological Status of Medical Staff in Obstetrics and Gynecology Hospitals during the Omicron Pandemic Outbreak in China

    by Shuting Bao, Bangwu Chen, Ying Hu, Chee Shin Lee, Qi Wu, Menglin Zhou, Mengkai Du, Shuqi Zhu, Biao Xie, Jiuqiong Hu, et al.

    Background. Medical staff in China faced great challenges and psychological and physiological changes of varying degrees during the omicron epidemic outbreak. It is important to recognize the potential impact of these challenges on the mental health of medical staff and to provide appropriate resources and support to mitigate their effects. Methods. A total of 354 medical staff in two obstetrics and gynecology hospitals of different grades were included in this survey using convenience sampling. The cross-sectional self-report questionnaires survey was conducted using the Basic Characteristics Questionnaire, Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ-9), and Insomnia Severity Index (ISI). Results. There were 169 (47.7%) participants suffering from anxiety disorder. Working with fever, working in obstetrics, and working with protective clothing were the risk factors for anxiety in medical staff . One hundred and ninety-six (55.4%) participants were depressed. Working with fever and working in obstetrics were the risk factors for depression in medical staff . There were 117 (33.1%) participants suffering from insomnia. Working with fever, high educational level, and severe COVID-19 infection status were the risk factors for insomnia in medical staff . Moreover, medical staff in a provincial hospital were more anxious and depressed than those in a county hospital. At last, there were more participants working with fever in obstetrics . Conclusion. Anxiety disorder, depression, and insomnia were common among obstetrics and gynecology medical staff during the outbreak of omicron pandemic. During this period, more resources for psychological counselling should be provided to the hospital as well as more reasonable staffing arrangements, and working while having a fever is prohibited, especially in provincial hospital.


  • Open Access

    The heterogeneous associations between gestational weight gain and adverse pregnancy outcomes in gestational diabetes mellitus according to abnormal glucose metabolism

    by Qi Wu, Yunyan Chen, Hao Ma, Tao Zhou, Ying Hu, Zhaoxia Liang, Danqing Chen

    Objectives: The gestational weight gain (GWG) and hyperglycemia are two key factors affecting adverse pregnancy outcomes among women with gestational diabetes mellitus (GDM). We aimed to investigate the combinatorial effect of abnormal glucose metabolism and GWG on adverse outcomes in GDM. Methods: This retrospective cohort study included 2611 pregnant women with GDM in Women’s Hospital School of Medicine Zhejiang University. Bases on the OGTT glucose levels, we categorized the GDM cohort into three subgroups: impaired fasting glucose (IFG) group, impaired glucose tolerance (IGT) group, and combined impaired glucose (IFG&IGT) group. Results: Among pregnant women with IGT, insufficient GWG (IGWG) was an independent protective factor for pregnancy-induced hypertension syndrome (PIH) (aOR 0.55, 95% CI 0.32-0.95), macrosomia (0.38, 0.19-0.74) and large for gestational age (0.45, 0.32-0.62), as well as an independent risk factor for low birth weight infants (2.29, 1.24-4.22) and small for gestational age (1.94, 1.17-3.19); and excessive GWG (EGWG) was related to increased risks of PIH (1.68, 1.12-2.52), preterm delivery (1.82, 1.28-2.58), postpartum hemorrhage (1.85, 1.05–3.28), cesarean delivery (1.84, 1.38-2.46) and low body weight infants (2.36, 1.33-4.20). Moreover, EGWG was positively associated with PIH (3.27, 1.09–9.80) in the IFG group. But there were no significant associations between either IGWG or EGWG and any pregnancy outcomes in women with combined IFG&IGT. Conclusions: The relationships between GWG and adverse outcomes were modified by abnormal glucose metabolism in women with GDM. Our results suggest that more specific GWG recommendations according to their metabolic state are needed for GDM.


  • Open Access

    Chemerin-Induced Down-Regulation of Placenta-Derived Exosomal miR-140-3p and miR-574-3p Promotes Umbilical Vein Endothelial Cells Proliferation, Migration, and Tube Formation in Gestational Diabetes Mellitus

    by Lixia Zhang, Qi Wu, Shuqi Zhu, Yibo Tang, Yanmin Chen, Danqing Chen, Zhaoxia Liang

    Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes and fetoplacental endothelial dysfunction; however, the underlying mechanisms remain unknown. This study aimed to investigate the effect of placenta-derived exosomal miRNAs on fetoplacental endothelial dysfunction in GDM, as well as to further explore the role of chemerin to this end. Placenta-derived exosomal miR-140-3p and miR-574-3p expression (next-generation sequencing, quantitative real-time PCR), its interactions with cell function (Cell Counting Kit-8, Transwell, tube formation assay), chemerin interactions (Western blotting), and placental inflammation (immunofluorescence staining, enzyme-linked immunosorbent assay) were investigated. Placenta-derived exosomal miR-140-3p and miR-574-3p were downregulated in GDM. Additionally, miR-140-3p and miR-574-3p inhibited the proliferation, migration, and tube formation ability of umbilical vein endothelial cells by targeting vascular endothelial growth factor. Interestingly, miR-140-3p and miR-574-3p expression levels were negatively correlated with chemerin, which induced placental inflammation through the recruitment of macrophage cells and release of IL-18 and IL-1β. These findings indicate that chemerin reduces placenta-derived exosomal miR-140-3p and miR-574-3p levels by inducing placental inflammation, thereby promoting the proliferation, migration, and tube formation of umbilical vein endothelial cells in GDM, providing a novel perspective on the underlying pathogenesis and therapeutic targets for GDM and its offspring complications.


  • Open Access

    An early prediction model for gestational diabetes mellitus based on genetic variants and clinical characteristics in China

    by Qi Wu, Yanmin Chen, Menglin Zhou, Mengting Liu, Lixia Zhang, Zhaoxia Liang, Danqing Chen

    Objectives: To evaluate the influence of genetic variants and clinical characteristics on the risk of gestational diabetes mellitus (GDM) and to construct and verify a prediction model of GDM in early pregnancy. Methods: Four hundred seventy five women with GDM and 487 women without, as a control, were included to construct the prediction model of GDM in early pregnancy. Both groups had complete genotyping results and clinical data. They were randomly divided into a trial cohort (70%) and a test cohort (30%). Then, the model validation cohort, including 985 pregnant women, was used for the external validation of the GDM early pregnancy prediction model. Results: We found maternal age, gravidity, parity, BMI and family history of diabetes were significantly associated with GDM (OR > 1; P < 0.001), and assisted reproduction was a critical risk factor for GDM (OR = 1.553, P = 0.055). MTNR1B rs10830963, C2CD4A/B rs1436953 and rs7172432, CMIP rs16955379 were significantly correlated with the incidence of GDM (AOR > 1, P < 0.05). Therefore, these four genetic susceptible single nucleotide polymorphisms (SNPs) and six clinical characteristics were included in the construction of the GDM early pregnancy prediction model. In the trial cohort, a predictive model of GDM in early pregnancy was constructed, in which genetic risk score was independently associated with GDM (AOR = 2.061, P < 0.001) and was the most effective predictor with the exception of family history of diabetes. The ROC-AUC of the prediction model was 0.727 (95% CI 0.690–0.765), and the sensitivity and specificity were 69.9% and 64.0%, respectively. The predictive power was also verified in the test cohort and the validation cohort. Conclusions: Based on the genetic variants and clinical characteristics, this study developed and verified the early pregnancy prediction model of GDM. This model can help screen out the population at high-risk for GDM in early pregnancy, and lifestyle interventions can be performed for them in a timely manner in early pregnancy.


  • Open Access

    Relationship of abnormal mid-term oral glucose tolerance test and maternal weight gain with adverse pregnancy outcomes in women with gestational diabetes mellitus

    by Yunyan Chen, Qi Wu, Lixia Zhang, Danqing Chen, Zhaoxia Liang

    目的 探讨妊娠期糖尿病(gestational diabetes mellitus,GDM)患者孕中期75g口服葡萄糖耐量试验(oral glucose tolerance test ,OGTT)血糖指标异常项数及孕期增重对妊娠结局的影响。方法 纳入2017年7月1日至2018年6月30日在浙江大学医学院附属妇产科医院定期产前检查并分娩的2611例GDM孕妇,根据孕中期OGTT血糖异常项数分为GDM I组(1项升高)、GDM II组(2项升高)和GDM III组(3项均升高),根据孕期体重增长分为增重不足组、增重适宜组及增重过多组,分析各组不良妊娠结局及两者的交互作用。结果 (1)GDM III组妊娠期高血压疾病、早产、巨大儿和大于胎龄儿(large for gestational age,LGA)发生率明显高于GDM II组、GDM I组;GDM Ⅱ组妊娠期高血压疾病和早产发生率也明显高于GDM I组。(2)孕期增重过多组妊娠期高血压疾病、巨大儿发生率明显高于增重不足及增重适宜组,LGA发生率明显高于增重不足组;增重适宜组早产和低出生体重儿发生率明显低于增重不足组及增重过多组,小于胎龄儿 (small for gestational age, SGA)发生率明显低于增重不足组。(3)在GDM I组,孕期增重不足是发生早产、SGA的危险因素(OR 2.04,95%CI 1.42-2.93;OR 2.09,95%CI 1.17-3.73),是妊娠期高血压疾病、LGA的保护因素(OR 0.55,95%CI 0.31-0.97;OR 0.50,95%CI 0.37-0.68);孕期增重过多则是妊娠期高血压疾病、低出生体重儿的危险因素(OR 1.82,95%CI 1.11-2.98;OR 2.34,95%CI 1.01-5.39)。在GDMⅡ组中,孕期增重不足是巨大儿和LGA的保护因素(OR 0.38,95%CI 0.18-0.80;OR 0.50,95%CI 0.34-0.73)。而在GDM Ⅲ组中孕期增重与不良妊娠结局的发生无明显关联。结论 在GDM孕期管理中,对于OGTT一项或两项血糖升高孕妇,孕期体重合理管理可降低部分不良妊娠结局的发生风险;三项血糖均升高孕妇,除了孕期体重管理,需更严格的血糖监测并进行药物降糖等积极干预措施。


  • Second-trimester maternal lipid profiles predict pregnancy complications in an age-dependent manner

    by Qi Wu, Lixia Zhang, Licong Huang, Yu Lei, Lin Chen, Zhaoxia Liang, Menglin Zhou, Heng Xu, Yumei Zhou, Fei Wang, et al.

    Our objective was to investigate the combinatorial effect of maternal age and second-trimester maternal lipid profiles for pregnancy complications.